Erytech Pharma

USPTO Trademark & Patent Filings

Trademark applications and grants for Erytech Pharma. Erytech Pharma has 14 trademark applications. The latest application filed is for "PHAXIAM"

Company Profile

ERYtech Pharma
pharma erytech
ERYTECH PHARMA - Lyon FR
ERYTECH PHARMA - LYON FR
Erytech Pharma - Lyon FR
ERYTECH PHARMA - Lyons FR

State Incorporated	FRANCE
Entity Type	société anonyme (sa)
Address	60 Avenue Rockefeller Lyon FRANCE 69008

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks Patents

Patent Applications

Patent Application	Date
ARGININE DEIMINASE ENCAPSULATED INSIDE ERYTHROCYTES AND THEIR USE IN TREATING CANCER AND ARGINASE-1 DEFICIENCY 20220193208 - 17/689002 DUFOUR; Emmanuelle ; et al.	2022-06-23
METHOD OF TREATING A MAMMAL, INCLUDING HUMAN, AGAINST CANCER USING METHIONINE AND ASPARAGINE DEPLETION 20220040272 - 17/410485 AGUERA; Karine ; et al.	2022-02-10
SYNERGISTIC COMBINATIONS OF METHIONINE DEPLETION AGENTS AND IMMUNE CHECKPOINT MODULATORS 20210403571 - 17/293708 BOURGEAUX; Vanessa ; et al.	2021-12-30
METHOD OF INDUCING IMMUNE TOLERANCE BY ADMINISTERING ACTIVE PRINCIPLE-LOADING RBC's 20210268082 - 17/169357 GODFRIN; Yann ; et al.	2021-09-02
COMPOSITION AND THERAPEUTIC ANTI-TUMOUR VACCINE 20210077602 - 17/000007 GODFRIN; Yann ; et al.	2021-03-18
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency 11,273,210 - 16/643,431 Dufour , et al. March 15, 2	2022-03-15
Arginine deiminase encapsulated inside erythrocytes and their use in treating cancer and arginase-1 deficiency 11,273,210 - 16/643,431 Dufour , et al. March 15, 2	2022-03-15
Method of treating a mammal, including human, against cancer using methionine and asparagine depletion 11,141,468 - 16/067,398 Aguera , et al. October 12, 2	2021-10-12
Method of treating a mammal, including human, against cancer using methionine and asparagine depletion 11,141,468 - 16/067,398 Aguera , et al. October 12, 2	2021-10-12
Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor 10,780,126 - 16/102,171 Godfrin , et al. Sept	2020-09-22

Patent Grants & Applications

Trademark Applications

Mark Image Registration \| Serial	Trademark Application Date
"PHAXIAM" 98114171	PHAXIAM 2023-08-02
"ERYGRASP" 90074278	ERYGRASP 2020-07-26
"ERYCAPS" 5461731 87176563	ERYCAPS 2016-09-20
"ERYTECH" 5221059 86966163	ERYTECH 2016-04-06
"Symbol/Image" 5108215 86966215	Symbol/Image 2016-04-06
"E ERYTECH PHARMA" 4398244 79117398	E ERYTECH PHARMA 2012-06-20
"ENHOXY" 4315267 79110577	ENHOXY 2012-02-10
"GRASPA" 3809410 77751705	GRASPA 2009-06-04
"ERYCAPS" 3669531 79056784	ERYCAPS 2008-07-08
"VACCIN'ERY SYSTEM" 3757687 79054949	VACCIN'ERY SYSTEM 2008-05-14
"GRASPA" 79047845	GRASPA 2007-11-26
"CLEAV'ERY SYSTEM" 3757672 79047846	CLEAV'ERY SYSTEM 2007-11-26
"OXYGEN'ERY SYSTEM" 3757673 79047847	OXYGEN'ERY SYSTEM 2007-11-26
"ERYTECH PHARMA" 3757674 79047848	ERYTECH PHARMA 2007-11-26

Company Registrations

NCAGE Code	FB5L4	ERYTECH PHARMA
CAGE Code	FB5L4	ERYTECH PHARMA

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.